A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis

Objective: The objective of the study was to confirm the efficacy and safety of Astodrimer 1% Gel to prevent recurrence of bacterial vaginosis. Study design: 864 women with a diagnosis of bacterial vaginosis and a history of recurrent bacterial vaginosis were enrolled in North America and first rece...

Full description

Bibliographic Details
Main Authors: Jane R. Schwebke, Belvia A. Carter, Arthur S. Waldbaum, Kathy J. Agnew, Jeremy R.A. Paull, Clare F. Price, Alex Castellarnau, Philip McCloud, George R. Kinghorn
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Subjects:
Astodrimer Gel
Bacterial vaginosis
Biofilm
Prevention
Recurrent bacterial vaginosis
SPL7013
Online Access:http://www.sciencedirect.com/science/article/pii/S2590161321000016

Internet

http://www.sciencedirect.com/science/article/pii/S2590161321000016

Similar Items